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Polyethylenimine  (PEI)  has  been  used  as  a vehicle  to  deliver  genes  to  cancer  cells  and  somatic  cells.  In  this
study,  cationic  polymers  of PEI were  shielded  with  anionic  polymers  of  hyaluronic  acid  (HA)  to safely  and
effectively  deliver  genes  into  human  mesenchymal  stem  cells  (hMSCs).  HA interacted  with  CD44  in the
plasma  membranes  of hMSCs  to facilitate  the  internalization  of HA-shielded  PEI/pDNA  complexes.  The
HA-shielded  PEI/pDNA  nanogels  were  conﬁrmed  by  size  changes,  -potential,  and gel retardation  assays.
HA-shielded  nanogels  were  easily  internalized  by hMSCs,  and  this  was  reduced  by pretreatment  with  aEI
yaluronic acid
MSCs
D44
OX9
speciﬁc  monoclonal  antibody  that  blocked  CD44.  By shielding  PEI/pDNA  complexes  with HA,  nanogels
were  easily  internalized  to hMSCs  when  it did not  blocked  by anti-CD44.  These  shielded  nanogels  were
also easily  internalized  by  HeLa  cells,  and  this  was  reduced  by  pretreatment  with  an  anti-CD44  mono-
clonal  antibody.  Following  internalization  of  the SOX9  gene,  chondrogenesis  of  hMSCs  was  increased,  as
determined  by  RT-PCR,  real-time  quantitative  PCR,  and  histological  analyses.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license. Introduction
The CD44 glycoprotein is a speciﬁc receptor located at the cell
urface and plays crucial roles in multiple contexts, including cell-
ell binding, cell-matrix binding, cell movement, and cell homing
Bian et al., 2013; Guo et al., 2012; Nagase & Nakayama, 2013;
uintanilla, Asprer, Vaz, Tanavde, & Lakshmipathy, 2014; Wang
t al., 2014). CD44 in various types of stem cells functions in diverse
ctivities, such as cell adhesion, migration, homing, proliferation,
urvival, and death (Chen et al., 2014; Hanke et al., 2014; Kato
t al., 2014; Lamb, Lisanti, Clarke, & Landberg, 2014; Lim et al.,
013; White, Nash, Kavanagh, Savage, & Kalia, 2013). CD44 binds
yaluronan and hyaluronic acid (HA) via its N-terminus (Assmann,
enkinson, Marshall, & Hart, 1999; Malhotra, Laursen, Willis, & Sim,
993).
Monoclonal antibodies against CD44 or the addition of soluble
A have been used to detect interactions between CD44 and HA
Campo et al., 2012; Zhou, Weigel, Fauss, & Weigel, 2000). Inhibition
f CD44 using speciﬁc antibodies or HA reduces the production of
ytotoxic cells in bone marrow. Due to the multiple interactions of
A with cell surface molecules, HA-modiﬁed particles have been
sed to target drugs and genes for delivering into cells (Philipp,
∗ Corresponding author.
E-mail address: pkh0410@cha.ac.kr (K.-H. Park).
ttp://dx.doi.org/10.1016/j.carbpol.2015.09.053
144-8617/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
Zhao, Tarcha, Wagner, & Zintchenko, 2009; Yu et al., 2013a). The use
of HA-modiﬁed nanoparticles and nanogels for cancer treatment
has been evaluated in cancer cell lines (Li et al., 2014; Platt & Szoka,
2008).
In this regard, several studies have investigated CD44-mediated
delivery of particles into cells using HA (Almalik et al., 2013a;
Almalik et al., 2013b; Nasti et al., 2009). Nanoparticles composed
of HA can be used to easily deliver drugs into CD44-positive can-
cer via interactions with CD44, while conventional nanoparticles
have focused on the delivery of antibodies or peptide conjugates
into cancer cells (Choi, Jang, Kim, & Ahn, 2014; Cho et al., 2011;
Tiwari et al., 2014). HA-modiﬁed nanoparticles are easily internal-
ized by CD44-positive cell lines, without eliciting cytotoxic effects
(Gan et al., 2013).
Furthermore, in recent years, HA has been used for cartilage tis-
sue engineering using stem cells (Frith et al., 2014; Jung et al., 2014;
Kim, Khetan, Baker, Chen, & Burdick, 2013). The injection of cells
complexed with various types of soft and biodegradable hydro-
gels into defect sites to promote cartilage formation has attracted
much attention because it avoids the need for open surgery. Binding
between CD44 and HA stimulates a cascade of signaling pathways
that stimulate the differentiation of stem cells into chondrocytes
(Toh, Lim, Kurisawa, & Spector, 2012; Wu  et al., 2013). Several
studies have investigated the use of HA derivatives for cartilage
tissue engineering (Gerard et al., 2005; Yu, Cao, Zeng, Zhang,
& Chen, 2013b). HA derivatives were chemically modiﬁed with
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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lginate or ﬁbrin gel matrices to generate a microenvironment
uitable for scaffolds of chondrocytes or mesenchymal stem cells
Chung et al., 2011). The addition of soluble HA reportedly trigg-
rs the proliferation and differentiation of chondrocytes (Hwang,
arghese, Li, & Elisseeff, 2011; Lu et al., 2013).
The purpose of this study was to evaluate receptor-mediated
ene delivery into human mesenchymal stem cells (hMSCs) using
A-modiﬁed nanogels. There are a few studies of the use of
anogels harboring ligands of speciﬁc receptors to deliver genes
nto stem cells (Levett et al., 2014). In this study, surface-modiﬁed
anogels were prepared using various ratios of polyethylenimine
PEI) to HA. By increasing the PEI:HA ratio, HA-modiﬁed nanogels
ere readily internalized via receptors located in the plasma mem-
rane.
. Materials and methods
.1. Materials
.1.1. Chemicals
Linear polyethylenimine (PEI, 25 kDa) was purchased from
olyscience Inc. (Touhy Avenue, Niles, USA). Both 30% (29:1)
crylamide/bis-acrylamide stock solution and RIPA buffer were
urchased from Bio-Rad Laboratories, Inc. (Royall St. Canton,
SA). Alpha-minimum essential medium (-MEM), antibiotic-
ntimycotic, and 0.25% trypsin were purchased from Invitrogen
ife Technologies Corp. (Grand Island, NY, USA). Fetal bovine serum
FBS) was purchased from Thermo Fisher Scientiﬁc Inc. (Wyman St.,
altham, USA). All other chemicals and reagents were purchased
rom the Sigma Chemical Company (St. Louis, MO,  USA).
.1.2. Cell culture
Human MSCs (Cambrex, Walkersville, PT-2501, USA) were
btained from bone marrow harvested from proximal femur sam-
les, removed during hip replacement surgery, from a 20-year-old
ale. The patient provided informed consent, and the local ethical
ommittee approved the use of the sample for research. hMSC were
ultured in Alpha-minimum essential medium (-MEM)  supple-
ented with 10% fetal bovine serum (FBS; Thermo Fisher Scientiﬁc
nc., Waltham, MA,  USA) and antibiotic-antimycotic solution (Life
echnologies, Carlsbad, CA, USA) at 37 ◦C in a 5% CO2 atmosphere.
eLa cells (American Type Culture Collection, Manassas, VA, USA)
ere cultured in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
Thermo Fisher Scientiﬁc Inc., Waltham, MA,  USA). The harvested
ells were maintained in DMEM supplemented with 10% FBS and
ntibiotic-antimycotic solution at 37 ◦C in a 5% CO2 atmosphere.
.2. Preparing experimental procedures
.2.1. Rhodamine isothiocyanate (RITC)-conjugated HA (R-HA)
Oligo-HA (50 mg,  8.62 mol) and RITC (5.55 mg,  10.34 mol)
ere dissolved in deionized water (DW, 10 mL)  and DMSO (2 mL),
espectively. Two reactant solutions were mixed and stirred at
oom temperature. After 12 h, the reaction solution was dialyzed
sing a dialysis membrane (Spectra/Por; mol. wt. cutoff size, 1000)
gainst DW for 2 days. The ﬁnal products were lyophilized.
.2.2. Preparation of HA (Hyaluronic acid) shielded PEI/pDNA
anogels
PEI/pDNA (EGFP; green ﬂuorescent protein reporter gene) com-
lex was prepared by mixing PEI and pDNA in HEPES-buffered
aline, and shielded various HA ratio (ratio of the amine group in PEI
o the carboxylic group in HA). The HA shielded PEI/pDNA nanogels
ere incubated for 10 min  at room temperature. The HA shielded
EI/pDNA nanogels were prepared at the ratio PEI(pDNA):HA of
:0.5–20.mers 136 (2016) 791–802
2.2.3. Preparation of expression vectors
The full-length human SOX9 (hSOX9) cDNA was ampliﬁed from
a hSOX9 clone (ATCC, Manassas, VA, USA). The EGFP-hSOX9 expres-
sion plasmid (pEGFP-SOX9) were generated by ligating the hSOX9
open reading frame into pEGFP- N3 (Clontech, Mountain View, CA,
USA), which encodes a green ﬂuorescent protein. The EGFP expres-
sion plasmid (pEGFP) was  generated by ligating the EGFP open
reading frame derived from pEGFP-N3 into pcDNA3.1/hyg (Invi-
trogen, Carlsbad, CA, USA). All plasmid constructs were veriﬁed by
DNA sequencing.
2.3. Charaterization of HA shielded PEI/pDNA nanogels
2.3.1. Dynamic light scattering (DLS)
Particle sizes of HA shielded PEI/pDNA nanogels were deter-
mined by DLS. Measurements were carried out with Zeta Sizer Nano
ZS apparatus (Malvern, Southborough, MA). Freshly prepared HA
shielded nanogel suspensions (800 l) were placed in a cuvettes
without dilution. The measurement was carried out using a 4 mW
He–Ne laser (633 nm)  as light source at a ﬁxed angle of 173◦. Each
size measurement included at least 12 runs. All measurements
were carried out in triplicate, and the results were expressed as
the mean size ± SD.
2.3.2. -Potential measurements
The -potential of pDNA, PEI, HA, and HA shielded PEI/pDNA
nanogels were measured at room temperature by Zeta Sizer
(Malvern, Southborough, MA). Samples were prepared in dispos-
able capillary cells (DTS1070) without dilution. The measurements
were performed under conditions of low ionic strength where the
surface charge of the particles can be measured accurately. All mea-
surements were carried out at 25 ◦C in triplicate, and the results
were expressed as means ± SD.
2.3.3. Atomic force microscopy (AFM)
To obtain images about the substructure and morphology
of HA shielded nanogels, AFM measurements were conducted
on an NanoWizard I (JPK Instruments, Berlin, Germany) by
high-resolution type of scanning probe microscope. Height mea-
surements and surface roughness were obtained using NanoWizard
AFM image analysis software (JPK Instruments, version 2.1).
2.3.4. Scanning electron microscopy (SEM)
The mean diameter, and surface morphology of HA shielded
PEI/pDNA nanogel suspensions were characterized by FE-SEM. The
morphology of HA shielded PEI/pDNA nanogels were observed
at 3 kV using a scanning electron microscope (FE-SEM, S-4700,
Hitachi, Japan).
2.4. Gel retardation assay
pDNA, HA, PEI/pDNA, and HA shielded PEI/pDNA nanogels were
loaded in the well of 1% agarose gel containing ethidium bro-
mide, which was applied to 100 V electrodes in 0.5× TAE buffer
for 20 min. DNA bands were visualized and photographed using a
UV trans-illuminator and Gel Doc imaging system (Bio-Rad Labo-
ratorie, Hercules, CA, USA).
2.5. Cell viability
A quantitative colorimetric assay was performed using Cell
Counting Kit-8 (Dojindo Molecular Technologies, Kumamoto,
Japan) for the evaluation of cytotoxicity of pDNA, HA, PEI/pDNA,
and HA shielded PEI/pDNA nanogels. Human MSCs was  seeded at
a density of 5 × 104 cells/well in 12-well plate and incubated for
overnight in the 5% CO2 incubator. hMSCs were treated HA, PEI,
te Polymers 136 (2016) 791–802 793
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Table 1
PCR primer sequences and product sizes.
Gene Sequence (5′ → 3′) Size (bp)
Aggrecan
(Sense) CCTTGGAGGTCGTGGTGAAAGG
280(Antisense) AGGTGAACTTCTCTGGCGACGT
COMP
(Sense) CAGGACGACTTTGATGCAGA
360(Antisense) AAGCTGGAGCTGTCCTGGTA
SOX9
(Sense) TTCATGAACTTGACCGACGA
290(Antisense) CACACCATGTTCGCGTTCAT
COXII
(Sense) GCACCCATGGACATTGGAGGG
366(Antisense) GACACGGAGTAGCACCATCGJ.S. Park et al. / Carbohydra
nd HA shielded nanogels with PEI(pDNA):HA ratio of 1:0.5, 1, 2, 5,
0, and 20 for 6 h. The medium was then replaced with 1 mL  of fresh
edium containing 10% FBS, 1% antibiotics from each polyplex
olution. After a 48 h incubation, the medium was  replaced with
 mL  of the medium containing 10% FBS and 10% CCK-8, followed
y incubation at 37 ◦C for additional 2 h. The absorbance values
ere measured by using VERSAmax microplate reader (Molecu-
ar Devices, Sunnyvale, CA, USA) at wavelength 450 nm,  with each
easurement repeated three times.
.6. Cellular uptake
.6.1. Interactions of CD44 with HA
HeLa cells or human MSCs were seeded in 6-well plate at a den-
ity of 4 × 105 or 2 × 105 cells/well and incubated for 24 h. Then
insed twice and pre-incubated for 1 h in 2 mL  serum-free medium
t 37 ◦C. Different ratio of PEI(pDNA): RITC conjugated HA (R-HA)
ere added to the cells. After 6 h, the cells were rinsed with PBS
n order to remove free nanogels, trypsinized and analyzed by
uava EasyCyte System (Guava Technologies, Hayward, CA, USA)
quipped with a 583/26 nm laser. The data shown are the mean
uorescent signals for 7000 cells.
HeLa cells or Human MSCs were seeded at a density of 2 × 105
ells/well in 6-well plate over cover-glass slide. Cells were incu-
ated with R-HA shielded PEI/pDNA nanogels for 30 min, 1 h,
 h, and 6 h at 37 ◦C. The cells were washed twice with cold
BS and ﬁxed with 1% paraformaldehyde (PFA) for 1 h at 4 ◦C.
he cells were washed twice with 1 mL  PBS to remove 1% PFA
nd then incubated in DAPI for 2 min. Cells on cove-glass were
ounted in aqueous mounting medium (Biomeda, Foster City, CA,
SA) and observed with confocal microscopy (LSM 510 META,
eiss). The ﬂuorescence was monitored in three channels: FITC
for DiO cell-labeling solution, CellLight® Early Endosomes-GFP,
r Alexa Fluor® 488 Goat Anti-Rabbit IgG (H + L) Antibody; excita-
ion 488 nm,  emission 518 nm), RITC (for R-HA nanogels; excitation
58 nm,  emission 583 nm), and DAPI (for nucleic acid; 40,6-
iamidino-2-phenylindole; excitation 358 nm,  emission 461 nm).
he magniﬁcation objective lens was 40×.
.6.2. Anti-CD44 antibody blocking
hMSCs were pre-incubated for 2 h at 37 ◦C with 0.2 g/2 × 105
ells of monoclonal anti-CD44 antibody (Santa Cruz, CA, USA)
iluted in Alpha-minimum essential medium (-MEM)  prior to
ddition of R-HA shielded PEI/pDNA nanogels.
.7. Transfection experiment
The hMSCs were plated in a 6-well (2 × 105 cells/well) plate, cul-
ured at 37 ◦C under 5% CO2, and then rinsed twice with cold PBS
nd pre-incubated for 2 h with 1 mL  Anti-CD44 blocking medium at
7 ◦C. After blocking, the culture medium was replaced with 2 mL
f Opti-MEM medium and cells were treated with R-HA shielded
EI/pDNA nanogels at the different ratio of 1:1, 1:5, and 1:10 for 6 h.
fter 6 h incubation, 2 mL  of culture medium with FBS was  added
nto each well to replace the complete medium, and cells were
urther incubated for 48 h post-transfection. The transfection efﬁ-
iency was calculated by the ﬂow cytometry (Guava Technologies,
ayward, CA, USA), and ﬂuorescence confocal microscopy (LSM 510
ETA, Zeiss).
.8. Pellet cultureFor preparation of each pellet, aliquots of 1 × 106 cells in 1 mL  of
eﬁned medium were spun down at 1200 rpm for 3 min  in a 15 mL
onical tube. Pellets were divided into 3 experimental groups in
he complete medium (containing 10% FBS, and 1% antibiotics) andGADPH
(Sense) TCACAATCTTCCAGGAGCGA
336(Antisense) CACAATGCCGAAGTGGTCGT
cultivated at 37 ◦C, and 5% CO2 for 21 days by changing the medium
every 2 days.
2.9. Measurement of total DNA, and sGAG contents
For sulfated glycosaminoglycan assay (BlyscanTM; Biocolor Ltd.,
Carrickfergus, UK), the samples (n = 5/group) were fully digested
for 4 h at 65 ◦C in papain digestion solution. The GAG content was
determined using a 1,9-dimethylmethylene blue dye (DMB). In
brief, 1 mL  of a papain-digested sample was  incubated with 2 mL  of
DMB  dye, and the reaction was  observed on a spectrophotometer at
655 nm with chondroitin sulfate C (Sigma) used as a standard. The
number of cells was  determined by measuring the double-stranded
DNA content using a PicoGreen assay (Molecular Probes, Eugene,
OR), according to the manufacturer’s instructions. The total amount
of GAG was  normalized against the total amount of DNA.
2.10. RT-PCR, and quantitative real-time PCR (qPCR)
After 3 weeks in pellet culture, total RNA was  isolated from the
cell pellet using the TRIzol® (Invitrogen; Carlsbad, CA) in accor-
dance with the manufacturer’s instructions. Total RNA (0.5 g) was
reverse-transcribed in a 20 l reaction using MMLV  reverse trans-
criptase and random hexamers. The PCR reactions were conducted
using 2X SeeAmpTM ACPTM Master Mix  II (Seegene, Seoul, Korea)
under the following conditions: 94 ◦C for 5 min  followed by 35
cycles of 20 s of denaturation at 94 ◦C, 45 s of annealing at 57 ◦C-
61 ◦C, and 45 s of extension at 72 ◦C. PCR products were conﬁrmed
on 1.2% agarose gel and visualized under UV light after ethidium
bromide staining. All PCR primers were indicated in Table 1.
Additionally, speciﬁc gene expression was  measured via real-
time PCR in an ExiCycler (Bioneer, Daejeon, Korea). In brief, 1 l of
each cDNA was  ampliﬁed in a 20 l PCR assay containing 1.5 mM
MgCl2, 20 pM of each primer, and 1× Takara PCR Master Mix
(Takara, Otsu, Japan). Samples were then subjected to the following
conditions in an ExiCycler: initial denaturation at 94 ◦C for 10 min
followed by 45 cycles of 94 ◦C for 40 s, 58 ◦C for 30 s, and 72 ◦C for
30 s. Relative quantiﬁcation was calculated via the 2-delta delta ct
(cycle-threshold) method. In order to conﬁrm the ampliﬁcation of
speciﬁc transcripts, melting curve proﬁles were generated at the
end of each PCR by cooling the sample to 40 ◦C and then heating it
slowly to 95 ◦C while continuously measuring the ﬂuorescence.
2.11. Western blot analysis
Transfected cells were lysed with RIPA cell lysis buffer (GenDE-
POT, Barker, Texas, USA; 150 mM sodium chloride, 1% Triton X-100,
1% sodium deoxycholate, 0.1% SDS, 50 mM Tris–HCl, 2 mM EDTA,
and 0.005% protease inhibitors). Protein concentration was deter-
mined using the BCA Protein Assay Kit. Equal amounts of protein
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Fig. 1. Dynamic light scattering (DLS), atomic force microscopy (AFM), and scanning electron microscopy (SEM) analyses and the -potentials of various hyaluronic acid
(HA)-shielded nanogels.
(A) Size distributions of HA-shielded nanogels: a, d, and g: DLS analysis of HA-shielded nanogels with various polyethylenimine (PEI):HA ratios. b, e, and h: AFM images of
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tA-shielded nanogels with various PEI:HA ratios. c, f, and i: SEM images of HA-shie
EI:HA  ratio of 1:1 (a–c), 1:5 (d–f), or 1:10 (g–i).
B) HA-shielded nanogel surface charges, as evaluated by -potential. HA-shielded 
30–50 g/well) were loaded into 8–10% (w/v) SDS-polyacrylamide
els and electrophoresed at 80–100 V for 2 h. Proteins were trans-
erred to membranes, which were subsequently blocked with 2.5%
kimmed milk prepared in Tris-buffered saline containing 0.2%
ween 20 and incubated with primary antibodies against GFP
1:5000, Clontech Laboratories Inc.), -actin (1:10,000, Sigma),
OX9, collagen type II (COL II; 1:3000; Chemicon, Temecula,
A, USA), and aggrecan (1:2000; Abcam, Cambridge, UK). Blots
ere developed using enhanced chemiluminescence reagents (GE
ealthcare, Little Chalfont, UK).
.12. Histological and immunohistochemical analysis of the pellet
After 21 days of culturing, cell pellets ﬁxed in 4% paraformalde-
yde (PFA) for 1 h. Samples were embedded in O.C.T. compound
Tissue-Tek 4583, Sakura Finetek, USA) and 8-m sections were
ut. Hematoxylin and Eosin (H&E) staining of sections was  done for
valuation of cell morphology in pellets. Sulfated glicosaminogli-
ans (GAG) were visualized by staining with Alcian Blue, and,
afranin-O for 15 min, and sections (8-m)  were stained with
on Kossa, and Alizarin Red-S for extracellular matrix calciﬁca-
ion. Immuno-staining was performed using an anti-COL II (1:200),anogels with various PEI:HA ratios. Scale bar, 200 nm.  HA-shielded nanogels had a
els had a PEI:HA ratio of 1:1 (a), 1:5 (b), or 1:10 (c).
and anti-SOX9 (1:200) primary antibody. The sections were rinsed
with PBS and treated with 4% PFA for 15 min, 0.1% Triton X-100 for
10 min, and 1% BSA in PBS for 10 min. After blocking, sections were
applied as a primary antibody at 4 ◦C, for 2 h. And then rinsed with
PBS and incubated with Alexa Fluor 488-conjugated anti-rabbit
immunoglobulin G (Molecular Probes, Eugene, OR, USA). Samples
were washed with PBS three times and incubated for 5 min with
1:500 DAPI (4′,6-diamidino-2-phenylindole) stain. The cells were
then examined under a Zeiss LSM 510 META confocal microscope
(Carl Zeiss, Gottingen, Germany).
2.13. Statistical analyses
Student’s t-test was used for all statistical analyses. * P < 0.05 and
** P < 0.01 were considered to be statistically signiﬁcant.
3. Results3.1. Characterization of HA-shielded nanogels
The sizes of various HA-shielded PEI/pDNA nanogels were mea-
sured by DLS. The nanogel size increased as the PEI:HA ratio
J.S. Park et al. / Carbohydrate Polymers 136 (2016) 791–802 795
Fig. 2. Uptake of hyaluronic acid (HA)-shielded nanogels by human mesenchymal stem cells (hMSCs).
(A)  Percentage of hMSCs that internalized HA-shielded nanogels as determined by ﬂuorescence-activated cell sorting. a: Uptake of HA-shielded nanogels with various
polyethylenimine (PEI):HA ratios. b: Uptake of HA-shielded nanogels (PEI:HA = 1:10) over time.
(B)  Uptake and intracellular trafﬁcking of HA-shielded nanogels by hMSCs after 6 h, as determined by confocal laser microscopy. a and d: PEI:HA = 1:1, b and e: PEI:HA = 1:5,
and  c and f: PEI:HA = 1:10. Scale bar, 50 m.
(C) Intracellular localization of HA-shielded nanogels. Staining of early endosomes in hMSCs treated with nanogels (PEI:HA = 1:10) for various amounts of time. Green
represents early endosomes and red represents rhodamine isothiocyanate (RITC)-labeled HA. a–c: 30 min  of treatment; d–f: 1 h of treatment; g–i: 3 h of treatment; and j–l:
6  h of treatment. Scale bar, 20 m.
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cD) Percentage of hMSCs that internalized HA-shielded nanogels via CD44. a: Contr
E)  Immunostaining of HA (green) following treatment with HA-shielded nanogels.
ncreased (Fig. 1A, a, d, and g). Nanogels with a PEI:HA ratio of 1:1
ere approximately 70 nm (Fig. 1A, a). For nanogels with a PEI:HA
atio of 1:5, the size increased to 120 nm (Fig. 1A, d). Nanogels with
 PEI:HA ratio of 1:10 reached 150 nm (Fig. 1A, g). DLS analyses of
he other nanogels (PEI:HA ratios of 1:0.5 and 1:2) are shown in
igure S2.
We also observed the sizes of HA-shielded PEI/pDNA nanogels
ith various PEI:HA ratios by performing AFM and SEM. In
oth analyses, the size of nanogels increased as the PEI:HA ratio
ncreased (Fig. 1, e, f, h, and i). Furthermore, the sizes determined
y AFM and SEM were consistent with those determined by DLS.
A-shielded PEI/pDNA nanogels were large when the ratio of PEI
o HA was high (Fig. 1A, h and i).The tight complexation of pDNA with HA-shielded PEI showed
hat the surface charge of this complex differed from those of pDNA,
A, and PEI (Fig. 1B). When more HA was added, the surface of the
omplexes became more negatively charged (Fig. 1B, c). By contrast,EI:HA = 1:1, c: PEI:HA = 1:5, and d: PEI:HA = 1:10.
trol, b: PEI:HA = 1:1, c: PEI:HA = 1:5, and d: PEI:HA = 1:10. Scale bar, 100 m.
the surface of the complexes was more positively charged when a
low amount of HA was  added (Fig. 1B, a). This indicates that HA on
the outer surface of PEI/pDNA complexes could interact with the
CD44 receptor on hMSCs.
3.2. Uptake of HA-shielded nanogels by hMSCs
The uptake of HA-shielded PEI/pDNA nanogels by hMSCs was
evaluated over 6 h (Fig. 2A). Nanogels with a PEI:HA ratio of 1:1,
1:5, and 1:10 were detected by ﬂuorescence-activated cell sorting
(FACS) (Fig. 2A, a). Nanogels with a PEI:HA ratio of 1:10 showed the
highest uptake by hMSCs over 6 h (Fig. 2A); 98% of hMSCs inter-
nalized nanogels. We  also evaluated the uptake of nanogels over
time (Fig. 2A, b). Uptake of nanogels with a PEI:HA ratio of 1:10
increased over time up to 6 h. At 3 h, 68% of hMSCs had taken up
these nanogels. This was markedly higher than the percentage of
cells that had taken up nanogels at 6 h when the PEI:HA ratio was
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Fig. 3. CD44-mediated uptake of hyaluronic acid (HA)-shielded nanogels by human mesenchymal stem cells (hMSCs).
(A) Confocal laser scanning microscopy images of hMSCs incubated with HA-shielded nanogels for 1 or 6 h. a–f: Without anti-CD44 antibody pretreatment. g–l: With anti-
CD44  antibody pretreatment. a, c, e, g, i, and k: 1 h of treatment. b, d, f, h, j, and l: 6 h of treatment. Green represents membranes, red represents rhodamine isothiocyanate
(RITC)-conjugated HA, and blue represents nuclei. a, b, g, and d: polyethylenimine (PEI):HA = 1:1; c, d, i, and j: PEI:HA = 1:5; and e, f, k, and l: PEI:HA = 1:10. Scale bar, 50 m.
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HB)  Percentage of hMSCs that internalized HA-shielded nanogels after 1 or 6 h. a and
:5. This indicates that HA-shielded nanogels with a PEI:HA ratio
f 1:10 easily entered hMSCs via binding to CD44 on the plasma
embrane.
The uptake of R-HA-shielded PEI/pDNA nanogels by hMSCs was
isualized by confocal laser microscopy (Fig. 2B). Cell membranes
ere stained and then nanogels were added. The nanogels, which
uoresced red, easily entered hMSCs when the PEI:HA ratio was
igh (Fig. 3B, c). The nanogels localized in the center of hMSCs, close
o the nucleus (Fig. 2B, f). However, nanogels with a low PEI:HA ratio
id not easily enter hMSCs (Fig. 2B, a and b) and did not localize at
he cell center (Fig. 2B, d and e).
We examined the uptake of HA-shielded PEI/pDNA nanogels
PEI:HA ratio of 1:10) over time (Fig. 2C). These nanogels were
bserved in the cytosol of hMSCs up to 6 h, and the intensity of
ytosolic red ﬂuorescence increased over time (Fig. 2C, k and l).
To conﬁrm that the uptake of HA-shielded PEI/pDNA nanogels
as mediated by CD44, these receptors and nanogels were detected
y FACS (Fig. 2D) and confocal laser microscopy (Fig. 2E). In
hese analyses, receptor-mediated internalization of nanogels was
learly observed. The CD44 ﬂuorescence signal decreased as the
EI:HA ratio increased (Fig. 2D, d). Receptor-mediated cellular
ptake of nanogels was reduced when the PEI:HA ratio was low
Fig. 2D, b).
Immunohistology was performed to assess receptor-mediated
nternalization of HA-shielded nanogels by hMSCs using speciﬁc
ntibodies against CD44 (green) and R-HA (red) (Fig. 2E). High levels
f ﬂuorescence were detected in hMSCs treated with nanogels with high PEI:HA ratio (Fig. 2E, d). In hMSCS treated with nanogels
ith a low PEI:HA ratio, the intensity of green ﬂuorescence was
igher than that of red ﬂuorescence (Fig. 2E, b). This shows that
A-shielded nanogels entered hMSCs via CD44 receptors.I:HA = 1:1, c and d: PEI:HA = 1:5, and d and e: PEI:HA = 1:10.
We  also investigated the complexation of pDNA with PEI of
a low molecular weight (1800 Da) and a high molecular weight
(25,000 Da) (Fig. S1). The viability of hMSCs treated with nanogels
generated using these two types of PEI did not differ (Figs. S1A and
S3B).
3.3. Inhibition of CD44-mediated cellular uptake of HA-shielded
nanogels
We  examined nanogel uptake by CD44-positive hMSCs (Fig. 3).
CD44 is typically used to characterize mesenchymal stem cells.
Thus, CD44-mediated delivery is an ideal means to target genes to
hMSCs. Even nanogels with a low PEI:HA ratio were easily internal-
ized (Fig. 3A, b). Nanogels in which this ratio was high were rapidly
taken up by hMSCs, as determined by confocal laser microscopy
(Fig. 3A, e). However, uptake of nanogels by hMSCs was highly
dependent on the presence of CD44 on the plasma membrane
(Fig. 3A, j and l). Red ﬂuorescence, indicative of R-HA, was not
detected in the cytosol of hMSCs pretreated with an anti-CD44
antibody. This shows that hMSCs require CD44 on their plasma
membranes to internalize HA-shielded nanogels.
We quantitated the level of nanogel uptake by hMSCs, with
or without anti-CD44 antibody pretreatment. Cellular uptake of
nanogels with a high ratio of PEI:HA was markedly decreased by
pretreatment with an anti-CD44 antibody (Fig. 3B, e and f). This
pretreatment decreased the percentage of hMSCs that had taken
up nanogels from 88.53% to 29.43% after 1 h (Fig. 3B, e) and from
96.32% to 35.44% after 6 h (Fig. 3B, f).
Evaluation of the uptake of several types of HA-shielded
nanogels by HeLa cells pretreated with an anti-CD44 antibody
showed that CD44 on plasma membranes was required for this
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Fig. 4. CD44-mediated internalization of hyaluronic acid (HA)-shielded nanogels complexed with genes by human mesenchymal stem cells (hMSCs).
(A)  Percentage of hMSCs transfected with HA-shielded nanogels complexed with the enhanced green ﬂuorescent protein (EGFP) gene. a–d: Without anti-CD44 antibody
pretreatment. e–h: With anti-CD44 antibody pretreatment.
(B) Western blot analysis of EGFP gene transfection into hMSCs using HA-shielded nanogels. a) Without anti-CD44 antibody pretreatment. b: With anti-CD44 antibody
pretreatment.
(C)  Densities of EGFP bands relative to those of -actin bands. a–d: Without anti-CD44 antibody pretreatment. e–h: With anti-CD44 antibody pretreatment. **P < 0.01.
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:  With anti-CD44 antibody pretreatment. Scale bar, 50 m.
ptake (Fig. S2). Thus, CD44 on plasma membranes greatly assisted
he entry of HA-shielded nanogels into cells.
.4. Gene transfection
hMSCs were treated with several types of HA-shielded nanogels
nd analyzed by FACS, Western blotting, and confocal laser
icroscopy (Fig. 4). To determine the abilities of these nanogels
o deliver genes to hMSCs, the EGFP gene was complexed with
EI and the resulting complexes were shielded with HA. The
GFP gene was easily delivered into hMSCs using HA-shielded
anogels; however, this was markedly inhibited by anti-CD44 anti-
ody pretreatment (Fig. 4 A, f–h). Anti-CD44 antibody pretreatment
ecreased the percentage of hMSCs expressing EGFP following
A-shielded nanogel treatment (PEI:HA = 1:10) from 39.23% to
6.34% (Fig. 4A). However, anti-CD44 antibody pretreatment did
ot change EGFP expression in hMSCs treated with nanogels that
ere not shielded with HA (PEI alone) (Fig. 4A, a and e). This shows
hat gene delivery using HA-shielded nanogels is dependent on
D44 at the plasma membrane.
Western blotting was performed to evaluate EGFP expressionn hMSCs following treatment with several types of HA-shielded
anogels, with or without anti-CD44 antibody pretreatment. EGFP
xpression in hMSCs was blocked by pretreatment with an anti-
D44 antibody (Fig. 4B). Anti-CD44 antibody pretreatment did notgels complexed with the EGFP gene. a: Without anti-CD44 antibody pretreatment.
affect EGFP expression in hMSCs treated with nanogels that were
not shielded with HA (PEI alone) (Fig. 4B, a and b).
In immunohistological analyses, EGFP was clearly expressed in
hMSCs treated with HA-shielded nanogels (Fig. 4C, b–d). However,
green ﬂuorescence was  markedly reduced in hMSCs pretreated
with an anti-CD44 antibody (Fig. 4C, f–h). Green ﬂuorescence was
not affected by anti-CD44 antibody pretreatment in hMSCs treated
with nanogels that were not shielded with HA (PEI alone) (Fig. 4C,
a and e). Thus, blockage of CD44 hindered the entry of HA-shielded
nanogels into hMSCs. We  tested the suitability of several types of
HA-shielded nanogels as gene delivery vehicles (Figs. S3 and S4).
Cells treated with nanogels with a PEI:HA ratio of 1:10 showed
the highest levels of gene transfection and expression. The SOX9
gene is important for chondrogenesis of mesenchymal stem cells.
Therefore, we  attempted to deliver this gene into hMSCs to induce
chondrogenesis. The SOX9 gene was tagged with EGFP and com-
plexed with PEI, and the complexes were shielded with HA. The
resulting nanogels were transfected into hMSCs and gene expres-
sion was evaluated over time by FACS (Fig. 5A). After 72 h, hMSCs
expressed EGFP-tagged SOX9, causing their differentiation into
chondrocytes.hMSCs treated with EGFP-tagged SOX9 gene-containing
nanogels were visualized by confocal laser microscopy (Fig. 5B) and
the level of EGFP was  quantiﬁed (Fig. 5D). EGFP-tagged SOX9 was
clearly observed in hMSCs at 24 h (Fig. 5B, c) and was maintained
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Fig. 5. CD44-mediated transfection of hyaluronic acid (HA)-shielded nanogels complexed with the enhanced green ﬂuorescent protein (EGFP)-tagged SOX9 gene.
(A)  Fluorescence-activated cell sorting analysis of human mesenchymal stem cells (hMSCs). a: Non-treated hMSCs; b: hMSCs treated with the EGFP-tagged SOX9 gene only;
c,  d, and e: hMSCs treated with HA-shielded nanogels containing the EGFP-tagged SOX9 gene for 24, 48, and 72 h, respectively.
(B)  Confocal laser scanning microscopy images of hMSCs. a: Non-treated hMSCs; b: hMSCs treated with the EGFP-tagged SOX9 gene only; c, d, and e: hMSCs treated with
HA-shielded nanogels containing the EGFP-tagged SOX9 gene for 24, 48, and 72 h, respectively. Scale bar, 50 m.
(C)  Western blot analysis of hMSCs. a, b, and c: Non-treated hMSCs cultured for 24, 48, and 72 h, respectively; d, e, and f: hMSCs treated with HA-shielded nanogels containing
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D) Densities of EGFP bands relative to those of -actin bands. a, b, and c: Non-tre
A-shielded nanogels containing the EGFP-tagged SOX9 gene for 24, 48, and 72 h, r
p to 72 h (Fig. 5B, e). The level of EGFP expression was  maintained
p to 72 h (Fig. 5D, f).
hMSCs express SOX9 protein. Thus, we evaluated EGFP-tagged
OX9 protein in hMSCs over 72 h (Fig. 5C). In Western blot anal-
sis, exogenous and endogenous SOX9 proteins were detected as
ands of 95 kDa and 72 kDa, respectively. In non-transfected cells,
ndogenous SOX9 was detected, whereas exogenous SOX9 was
ot detected at any time point (Fig. 5C, a–c). In hMSCs transfected
ith HA-shielded nanogels containing the EGFP-tagged SOX9 gene,
oth endogenous and exogenous SOX9 proteins were detected
Fig. 5C, d–f). Following transfection of the SOX9 gene, exogenous
nd endogenous SOX9 proteins were expressed to enhance chon-
rogenesis of hMSCs.
.5. Transfection of the SOX9 gene into hMSCs to induce
hondrogenesis
Following transfection of HA-shielded nanogels containing the
OX9 gene, hMSCs easily differentiated into chondrocytes. TohMSCs cultured for 24, 48, and 72 h, respectively; d, e, and f: hMSCs treated with
tively. **P < 0.01.
detect chondrogenesis of transfected hMSCs, RT-PCR, real-time
quantitative PCR, GAG content, and histological analyses were per-
formed (Fig. 6). During chondrogenesis of hMSCs, speciﬁc genes
were expressed, including aggrecan, COMP, SOX9, and COL II
(Fig. 6A). These chondrogenesis-related genes were most highly
expressed following treatment with HA-shielded nanogels con-
taining the SOX9 gene. mRNA expression of these genes was
highest following transfection of HA-shielded nanogels containing
the SOX9 gene (Fig. 6B).
The level of sGAG, an ECM component, was measured as an
indicator of chondrogenesis (Fig. 6C). Cells transfected with HA-
shielded nanogels containing the SOX9 gene produced signiﬁcantly
more sGAG than non-transfected cells.
To examine the ECM of hMSCs transfected with HA-shielded
nanogels containing the SOX9 gene, polysaccharides and pro-
teoglycans were stained with Alcian Blue and Safranin-O,
respectively (Fig. 6D). ECM calcium deposition, indicative of
osteogenesis, was visualized by Alizarin Red-S and von Kossa
staining (Fig. 6D). Following transfection of HA-shielded nanogels
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Fig. 6. Chondrogenesis of human mesenchymal stem cells (hMSCs) encapsulated in ﬁbrin gels after transfection of hyaluronic acid (HA)-shielded nanogels containing the
SOX9  gene, as evaluated by RT-PCR, real-time quantitative PCR, a sulfated glycosaminoglycan (sGAG) assay, and histology.
(A)  RT-PCR analysis of chondrogenesis-related markers produced by hMSCs. a: Non-treated hMSCs, b: hMSCs treated with polyethylenimine (PEI)-complexed SOX9, and c:
hMSCs treated with HA-shielded nanogels containing the SOX9 gene. COL II, collagen type II.
(B)  Real-time quantitative PCR analysis of chondrogenesis-related markers. a: Non-treated hMSCs, b: hMSCs treated with PEI-complexed SOX9, and c: hMSCs treated with
HA-shielded nanogels containing the SOX9 gene.
(C) sGAG assay. a: Non-treated hMSCs, b: hMSCs treated with PEI-complexed SOX9, and c: hMSCs treated with HA-shielded nanogels containing the SOX9 gene. *P < 0.05.
(D)  Histological analysis of chondrogenesis- and osteogenesis-related extracellular matrix components. a–e: Non-treated hMSCs, f–j: hMSCs treated with PEI-complexed
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nd  m:  Safranin-O staining; d, i, and n: Alizarin Red-S staining; and e, j, and o: von 
ontaining the SOX9 gene, production of chondrogenesis-related
nd osteogenesis-related ECM components was increased and
ecreased, respectively.
At the protein level, the chondrogenesis-related proteins aggre-
an, COL II, and SOX9 were highly expressed in hMSCs transfected
ith HA-shielded nanogels containing the SOX9 gene (Fig. 7A, c).
The chondrogenesis-related proteins SOX9 and COL II produced
y hMSCs were visualized by confocal laser microscopy (Fig. 7B).
evels of these proteins were high following transfection of HA-
hielded nanogels containing the SOX9 gene (Fig. 7B, k–m).
. DiscussionIn this study, we evaluated that the receptor-mediated gene
ransfection complexed with hyaluronic acid-modiﬁed nanopar-
icles were internalized into CD44+ receptor carrying human and k: Hematoxylin and eosin (H&E) staining; b, g, and l: Alcian Blue staining; c, h,
staining. Scale bar, 200 m.
mesenchymal stem cells (hMSCs) (Nagase et al., 2013) CD44+
receptor which mainly located on the speciﬁc cell membrane has
been to relate with several cell signaling including receptor–ligand
reaction that is induced by multicellular organisms to cause the
cell adhesion, proliferation, and cellular differentiation (Bian et al.,
2013; Guo et al., 2012; Nagase & Nakayama, 2013; Quintanilla et al.,
2014; Wang et al., 2014). Cell adhesion starts in the progress of ﬁrst
cellular viable actions via links to the certain space interacted with
receptors located in cellular membrane (Ke et al., 2014). When the
cells were cultured or transplanted in the condition of two  dimen-
sional culture system or wound site, they were led to search for
the anchoring site to bind (Almeda, Wang, & Auguste, 2015). This
mechanism provokes the cell proliferation, growth, and differenti-
ation.
In the case of capable gene delivery into cells, delivery vehi-
cles have been recently developed as a direction of increasing the
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Fig. 7. Chondrogenesis of human mesenchymal stem cells (hMSCs) after transfection of hyaluronic acid (HA)-shielded nanogels containing the SOX9 gene, as evaluated by
Western blot and histological analyses.
(A) Western blot analysis of chondrogenesis- and osteogenesis-related markers. a: Non-treated hMSCs, b: hMSCs treated with polyethylenimine (PEI)-complexed SOX9, and
c:  hMSCs treated with HA-shielded nanogels containing the SOX9 gene.
(B) Immunohistochemistry of chondrogenesis-related markers. a–d: Non-treated hMSCs, e–h: hMSCs treated with PEI-complexed SOX9, and i–l: hMSCs treated with HA-
shielded nanogels containing the SOX9 gene. a, e, and i: 4,6-Diamidino-2-phenylindole (DAPI) staining; b, f, and j: collagen type II (COL II) staining; c, g, and k: SOX9 staining,
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nnd  d, h, and i: merged images. Scale bar, 200 m.
ITC, ﬂuorescein isothiocyanate; RITC, rhodamine isothiocyanate.
ene expression efﬁciency due to increasing their internalization
s well as decreasing their cytotoxicity (Gerard et al., 2005; Yu
t al., 2013b). For these reasons, several types of carriers have been
esigned and selected biocompatible materials including organic
nd inorganic substance (Hwang, Varghese, Li, & Elisseeff, 2011; Lu
t al., 2013). Among them, the formations of nanostructure have
een recently employed as the adequate shapes for the complexa-
ion with genes (Yang et al., 2014). To facilitate the gene delivery,
anostructured vehicles showed potential strong points for the
nternalization into cells via endocytosis (Park, Yang, Woo, Jeon,
 Park, 2013a). In previous studies, we developed the PLGA NPs
oated with speciﬁc genes onto their outer surfaces which were
ested for the vehicles for stem cell differentiation (Jeon et al., 2014;
ark, Yang, Woo, Jeon, & Park, 2013b; Park, Yang, Woo, Jeon, & Park,
012). These nanostructured gene delivery vehicles clearly veriﬁed
hat the nanostructure formed PLGA NPs carrying speciﬁc genes
ncreased their intracellular uptaking capability into human mes-
nchymal stem cells (hMSCs). By delivering the speciﬁc genes into
ells effectively, the stem cells were easily switched into speciﬁc
omatic cells in response to the internalization of SOX9, C/EBP-,
nd Runx2 genes, respectively.
In this study, we employed the HA-modiﬁed nanogels, which
re consisting of speciﬁc biding sites for cells and complexing with
nionic carrying pDNA. This system can be easily internalized into
MSCs via speciﬁc cell receptors of CD44+ which were abundance
n stem cell membranes. For the evaluation of internalization of
A-modiﬁed nanogels, the RITC carrying them were tested by FACS
nalysis and confocal laser microscopy (Fig. 2). To conﬁrm the inter-
alization of HA-modiﬁed nanogels mediated by CD44, inhibitors ofreceptors located in cell membrane were employed and also evalu-
ated by FACS analysis and confocal laser microscopy (Fig. 3). In these
methods, receptor-mediated entering of HA-modiﬁed nanogels
into hMSCs was clariﬁed. Receptor-mediated cellular entering was
increased when the HA-modiﬁed nanogels were used. However,
their entering was  reduced when the inhibitors of CD44 was
pretreated into hMSCs (Fig. 3B, e and f). It means that the internal-
ization of nanogels into cells was  increased by speciﬁc ligands of
HA and reduced their internalization by pretreatment of anti-CD44
monoclonal antibodies.
In the case of gene transfection, the green ﬂuorescence protein
(GFP) plasmid DNA complexed in HA-modiﬁed nanogels was tested
using hMSCs (Fig. 4). For the detection of gene transfections into
cells, we  employed the Western blotting analysis for their protein
expressions in cells. By internalization of HA-modiﬁed nanogels
complexed with GFP genes, the expressions of GFP protein level
by HA-modiﬁed nanogels complexed with GFP pDNA showed the
high level by this analysis (Fig. 4A & B). Also, the expression levels
were reduced by inhibition of speciﬁc anti-CD44 pretreated cells.
It means that the internalization of HA-modiﬁed nanogels com-
plexes with genes were clearly increased via speciﬁc ligands of
them and then released the genes into cytosol of cells for expression
of speciﬁc proteins.
The stem cell differentiation was  clearly evaluated by inter-
nalization of HA-modiﬁed nanogels which were complexed with
SOX9 genes (Figs. 6 and 7). By RT-PCR analysis, the chondrogenic-
related mRNA levels including aggrecan, COMP, SOX9, and collagen
type II were highly expressed when the SOX9 genes were com-
plexed with the HA-modiﬁed nanogels. When the SOX9 genes
te Poly
w
e
g
t
d
T
H
t
t
b
I
d
E
f
w
o
n
T
i
S
i
n
p
s
e
w
q
H
5
f
b
a
H
b
s
c
a
n
d
A
o
2
A
t
R
A
A
AJ.S. Park et al. / Carbohydra
ere complexed with PEI, the chondrogenic-related mRNA levels
xpressions were not highly detected (Fig. 7). Also, in the amount of
lycosaminoglycan (GAG) produced from hMSCs, the most impor-
ant extracellular matrix (ECM) in cartilage tissue, there were some
ifferences whether SOX9 gene transfected cells or not (Fig. 7C).
he SOX9 pDNA transfected hMSCs showed better GAG production.
owever, the original hMSCs did not produce the GAG. It means
hat the cells transfected with SOX9 gene were started to switch
he chondrocytes.
Herein, we evaluated the chondrogenic differentiation of hMSCs
y transfection of SOX9 genes complexed in HA-modiﬁed nanogels.
n our guess, SOX9 genes are potential factors to induce chon-
rogenic differentiation. By transfection of SOX9 genes, speciﬁc
CMs, proteoglycan and polysaccharides, were highly produced
rom the hMSCs transfected with SOX9 pDNA whether complexed
ith PEI alone or HA-modiﬁed nanogels (Fig. 6D). However, the
steogenic differentiation-related ECMs, calcium deposition, were
ot clearly detected in the case of SOX9 pDNA transfected hMSCs.
his result was coincident with western blotting analysis and
mmunohistological analysis (Fig. 7A and B). It means that the
OX9 pDNA complexed with HA-modiﬁed nanogels internalized
nto hMSCs and then the SOX9 pDNA released from HA-modiﬁed
anogels from endosome in cytosol of them. And these escaped
DNA entered into nucleus of hMSCs and then the hMSCs were
witched into chondrocytes. The SOX9 pDNA showed quite inﬂu-
nce the chondrogenic differentiation of hMSCs for their binding
ith HA-modiﬁed nanogels. It means that the SOX9 pDNA was
uite easily entered into hMSCs when they were complexed with
A-modiﬁed nanogels.
. Conclusions
In this study, HA-shielded PEI/pDNA nanogels were fabricated
or receptor-mediated gene delivery into hMSCs. Cationic PEI can
e complexed with anionic pDNA via electrostatic interactions,
nd other cationic moieties bind to anionic HA to form nanogels.
A-shielded PEI/pDNA nanogels can bind to CD44 on plasma mem-
ranes to deliver genes and stimulate stem cell differentiation. The
ize of nanogels and the ratio of PEI to HA can inﬂuence the efﬁ-
iency with which HA-shielded PEI/pDNA nanogels enter hMSCs
nd deliver genes. Thus, we propose that HA-shielded PEI/pDNA
anogels can be used as gene delivery vehicles to induce stem cell
ifferentiation.
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